InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Albanna Amro A., 董事长兼首席执行官. Director active across 2 companies, notably Aditx Therapeutics, Inc.. Aggregated, 3 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €21k. History available since 1 June 2021. The latest transaction was filed on 19 July 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Amro A. Albanna is the Chairman and CEO of Aditx Therapeutics, Inc. He leads the company by defining the strategic vision and overseeing all operations. His role includes managing human resources, business development, and communication with shareholders. Through his leadership, he ensures that the company remains competitive in the market and meets the needs of its clients while achieving its financial objectives.